Central Nervous System (CNS)

We are committed to being a global player in CNS, expanding in psychiatry and creating an anchor in neurology through partnership and co-development. Our focus is on patients with neuropsychiatric disorders who have no adequate available treatments for epilepsy, stroke, depression and selected neurological diseases.

Epilepsy is the most common neurological disorder and can be defined as the condition of unprovoked, recurring seizures. It is thought that up to 5% of the worlds population may have some form of seizure in their life time. Only those with the recurring seizures will be diagnosed with Epilepsy. It can occur in male or female, adult or child.

The World Health Organization (WHO) estimate the prevalence to be approximately 8.2 per 1000 of the population. This equates to 50 million people across the world. It also means that there are approximately 100 million people who have either suffered from epilepsy, are suffering from epilepsy or will suffer from epilepsy.

Individuals with epilepsy may experience subtle interruptions of awareness and responsiveness to a major convulsion attack of the whole body. It cannot be considered as a single medical condition. There are many reasons why an individual would have these attacks, also known as seizures or fits.

Studies have shown that 70% of individuals diagnosed with Epilepsy can be treated successfully with anti epileptic drugs.

According to the WHO: Epilepsy is a chronic disorder characterized by recurrent seizures, which may vary from a brief lapse of attention or muscle jerks, to severe and prolonged convulsions. The seizures are caused by sudden, usually brief, excessive electrical discharges in a group of brain cells (neurones). In most cases, epilepsy can be successfully treated with anti-epileptic drugs.

Our Products